Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
about
Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.Exploring Microstructural Changes in Structural Analogues of Ibuprofen-Hosted In Situ Gelling System and Its Influence on Pharmaceutical PerformancePreparation and characterization of pluronic-colloidal silicon dioxide composite particles as liquid crystal precursorDevelopment of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study.Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.Drug release kinetics and physicochemical characteristics of floating drug delivery systems.Strategies for stimulation of new bone formation: a critical review.Lipid polymorphism in lyotropic liquid crystals for triggered release of bioactives.Oral delivery of peptides and proteins using lipid-based drug delivery systems.Self-Assembled Cubic Liquid Crystalline Nanoparticles for Transdermal Delivery of Paeonol.Topical formulations of serratiopeptidase: development and pharmacodynamic evaluation.QbD based approach for optimization of Tenofovir disoproxil fumarate loaded liquid crystal precursor with improved permeability.Serratiopeptidase Niosomal Gel with Potential in Topical Delivery.Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.Characterization of ternary phase diagrams by means of thermal and rheological analyses.Development and in vitro evaluation of alginate gel-encapsulated, chitosan-coated ceramic nanocores for oral delivery of enzyme.
P2860
Q34030782-236A31AF-51EE-4C91-BE96-116823FD4ADDQ36237892-68128167-8FF8-4188-8386-157C641FD038Q36360564-B59058FD-CBA9-4B18-9191-11E44EF52D5FQ37360582-27C45EBD-8731-4F22-816F-5D180F8CB934Q37360808-E75BF944-948A-4441-B6AB-1F68C446138CQ37790711-9B5C1B74-B7C1-47E9-A4BC-4D96EEE0BD50Q37867128-1988D4BA-C76C-433D-AD21-FE06C78A2326Q37970594-6E7E0B64-68D1-446B-9BC9-F3ECB0378B92Q38010647-FA79A34E-BB9A-4561-AAD8-CD474F101D60Q38035036-ED83ED11-0A0E-46F1-9EE6-D15E6C1D3871Q38948211-E59DF07F-1D54-4CC9-872C-586BBF7FAAADQ40965785-D9FB9BE9-4D6C-4499-AD8A-E31846ED55B5Q41272272-E20F22E1-B521-4572-8018-67DDF09BEB26Q41496823-5AFE5384-4CBC-4937-AC45-CF17C9665442Q43250329-6280D2EF-9BD5-4C7C-9D10-8C1E0A1E0D9CQ44583221-1155C66D-FB6B-4FB8-A7F5-0244CF084D81Q46732394-FF707BAB-B425-40D6-AA5F-31A83557E97D
P2860
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
@en
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
@nl
type
label
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
@en
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
@nl
prefLabel
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
@en
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
@nl
P1476
Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme
@en
P2093
Manish H Shah
P304
P356
10.1016/J.IJPHARM.2005.01.019
P407
P577
2005-04-01T00:00:00Z